摘要
目的:评估内镜下逆行阑尾炎治疗术(ERAT)治疗阑尾炎的疗效及安全性。方法:将2021年3月至2023年6月间收治的112例阑尾炎患者纳入研究,根据治疗方法,分为内镜下逆行阑尾炎治疗组(ERAT)组和腹腔镜下阑尾切除术(LA)组,比较ERAT组与LA组的治疗效果、患者的术后恢复情况、并发症及随访情况等。结果:ERAT组中有5例患者插管失败,1例患者由于术后肠穿孔转入外科行腹腔镜下阑尾切除术,LA组中1例患者术中转为开腹阑尾切除术,与LA组相比,ERAT组的手术时间、白细胞恢复正常时间、术后出院时间、并发症率均明显更低。结论:ERAT作为一种新型的治疗阑尾炎的方法,虽然有可能复发,手术失败等风险,但也具有创伤小、可保留阑尾、并发症少等优势,是除了LA外的另一种治疗阑尾炎的选择。
Objective: To evaluate the efficacy and safety of endoscopic retrograde appendectomy (ERAT) for the treatment of appendicitis. Method: 112 patients with appendicitis admitted between March 2021 and June 2023 were included in the study. According to the treatment method, they were divided into an endoscopic retrograde appendicitis treatment group (ERAT) and a laparoscopic appendectomy (LA) group. The treatment effect, postoperative recovery, complications, and follow-up of the ERAT group and the LA group were compared. Result: In the ERAT group, 5 patients failed intubation, 1 patient underwent laparoscopic appendectomy due to postoperative intestinal perforation, and 1 patient in the LA group underwent open appendectomy. Compared with the LA group, the ERAT group had significantly lower surgical time, white blood cell recovery time, postoperative discharge time, and complication rate. Conclusion: ERAT, as a novel method for treating appendicitis, may have risks such as recurrence and surgical failure, but it also has advantages such as minimal trauma, preservation of the appendix, and fewer complications. It is another choice for treating appendicitis besides LA.
出处
《临床医学进展》
2024年第4期2668-2673,共6页
Advances in Clinical Medicine